West Pharmaceutical Services Inc (WST)
314.77
-1.73
(-0.55%)
USD |
NYSE |
Nov 04, 16:00
316.20
+1.43
(+0.45%)
After-Hours: 20:00
West Pharmaceutical Services Enterprise Value: 22.63B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 01, 2024 | 22.63B |
October 31, 2024 | 22.01B |
October 30, 2024 | 22.38B |
October 29, 2024 | 22.77B |
October 28, 2024 | 22.19B |
October 25, 2024 | 22.01B |
October 24, 2024 | 23.66B |
October 23, 2024 | 20.46B |
October 22, 2024 | 20.45B |
October 21, 2024 | 20.54B |
October 18, 2024 | 20.98B |
October 17, 2024 | 20.64B |
October 16, 2024 | 20.66B |
October 15, 2024 | 20.81B |
October 14, 2024 | 21.12B |
October 11, 2024 | 21.09B |
October 10, 2024 | 20.74B |
October 09, 2024 | 20.48B |
October 08, 2024 | 20.48B |
October 07, 2024 | 20.77B |
October 04, 2024 | 21.21B |
October 03, 2024 | 21.27B |
October 02, 2024 | 21.45B |
October 01, 2024 | 21.45B |
September 30, 2024 | 21.47B |
Date | Value |
---|---|
September 27, 2024 | 22.32B |
September 26, 2024 | 22.04B |
September 25, 2024 | 21.76B |
September 24, 2024 | 22.23B |
September 23, 2024 | 22.01B |
September 20, 2024 | 22.11B |
September 19, 2024 | 22.33B |
September 18, 2024 | 22.19B |
September 17, 2024 | 21.22B |
September 16, 2024 | 21.29B |
September 13, 2024 | 21.57B |
September 12, 2024 | 21.34B |
September 11, 2024 | 21.69B |
September 10, 2024 | 21.92B |
September 09, 2024 | 21.67B |
September 06, 2024 | 21.32B |
September 05, 2024 | 21.54B |
September 04, 2024 | 21.86B |
September 03, 2024 | 21.82B |
August 30, 2024 | 22.51B |
August 29, 2024 | 22.59B |
August 28, 2024 | 21.35B |
August 27, 2024 | 21.71B |
August 26, 2024 | 21.78B |
August 23, 2024 | 21.72B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.341B
Minimum
Mar 23 2020
34.48B
Maximum
Dec 30 2021
22.66B
Average
22.93B
Median
Enterprise Value Benchmarks
Repligen Corp | 7.541B |
Perspective Therapeutics Inc | 524.04M |
Retractable Technologies Inc | -19.02M |
Xtant Medical Holdings Inc | 102.06M |
Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 136.00M |
Revenue (Quarterly) | 746.90M |
Total Expenses (Quarterly) | 581.20M |
EPS Diluted (Quarterly) | 1.85 |
Gross Profit Margin (Quarterly) | 35.44% |
Profit Margin (Quarterly) | 18.21% |
Earnings Yield | 2.14% |
Operating Earnings Yield | 2.54% |
Normalized Earnings Yield | 2.208 |